A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

NCT01128894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

841

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

BIOLOGICAL: albiglutide
DRUG: liraglutide

Sponsor

GlaxoSmithKline